Related Experiment Video
Updated: Jun 30, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Prognostic Significance of Atrial Cardiopathy in Patients with Embolic Stroke of an Undetermined Source
Yuan Chai1, Lulu Pei1, Lu Zhao1
1Department of Neurology, the First Affiliated Hospital of Zhengzhou University.
Insights
Atrial cardiomyopathy (AC) independently predicts recurrent stroke in patients with embolic stroke of an undetermined source (ESUS). Identifying AC improves risk stratification for these patients.
Area of Science:
- Cardiology
- Neurology
- Biomarkers
Background:
- Atrial cardiomyopathy (AC) is linked to cardiovascular events.
- The role of anticoagulation in embolic stroke of undetermined source (ESUS) is not fully understood.
- Prognostic value of AC in ESUS patients needs prospective evaluation.
Purpose of the Study:
- To prospectively assess the prognostic significance of atrial cardiomyopathy (AC) in patients with embolic stroke of undetermined source (ESUS).
- To determine if AC improves risk stratification for recurrent ischemic events and mortality in ESUS patients.
Main Methods:
- Prospective enrollment of 345 ESUS patients within 7 days of symptom onset.
- AC defined by NT-proBNP levels, P-wave terminal force in V1, or left atrial enlargement.
- Recurrence evaluated using Fine-Gray models; mortality assessed with Cox models.
Main Results:
- 42% of ESUS patients had AC.
- AC was strongly associated with recurrent ischemic stroke/TIA (aSHR 3.36, P<0.001).
- AC predicted all-cause mortality (aHR 3.80, P=0.024) and improved risk models (NRI, IDI).
Conclusions:
- Atrial cardiomyopathy is an independent predictor of recurrent ischemic stroke/TIA in ESUS.
- AC enhances risk stratification for ESUS patients.
- The association of AC with mortality in ESUS warrants further investigation due to limited events.
Aim:
Atrial cardiomyopathy (AC) is associated with cardiovascular events, but the benefit of anticoagulation in embolic stroke of an undetermined source (ESUS) remains unclear. We aimed to prospectively evaluate the prognostic value of AC in patients with ESUS.
Methods:
We prospectively enrolled patients with ESUS who were hospitalized within 7 days of onset (January 2019 - December 2021). AC was defined as an N-terminal pro-B-type natriuretic peptide level >250 pg/ml, P-wave terminal force in lead V1 >5000 µV·ms, or enlarged left atrial diameter. Ischemic stroke/transient ischemic attack (TIA) recurrence was evaluated using Fine-Gray sub-distribution hazard models with death as a competing event. Cox proportional hazards models were used for supportive analyses and all-cause mortality.
Results:
Among the 345 patients (mean age 59.22±13.19 years; 69.0% men), 42.0% met the criteria for AC. During a median follow-up of 18.1 months, 36 patients experienced ischemic stroke, 2 had TIA, and 18 died. AC was strongly associated with ischemic stroke/TIA recurrence in competing risk analyses (adjusted subdistribution hazard ratio [aSHR] 3.36, 95% CI 1.65-6.86; P<0.001). For all-cause mortality, AC was associated with a higher risk after adjusting for age and sex (adjusted hazard ratio 3.80, 95% CI 1.19-12.08; P = 0.024). Adding AC to conventional risk models significantly improved the NRI (ischemic stroke/transient ischemic attack: 72.45%, P<0.001; mortality: 66.16%, P = 0.002) and IDI (4.52%, P<0.001; 3.89%, P = 0.041).
Conclusions:
AC independently predicts recurrent ischemic stroke/TIA in ESUS and improves risk stratification, while its association with mortality requires cautious interpretation due to limited events.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Ischemic Stroke l: Introduction
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
